LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 349

Search options

  1. Article ; Online: Preferential rabbit antibody responses to C-termini of NOTCH3 peptide immunogens.

    Lee, Soo Jung / Gasche, Mitchell B / Burrows, Connor J / Kondepudi, Akhil / Zhang, Xiaojie / Wang, Michael M

    Scientific reports

    2023  Volume 13, Issue 1, Page(s) 9156

    Abstract: ... To shed light on the frequency of preferential rabbit antibody responses to C-termini of peptide ... of these polyclonal antibodies were determined to be C-terminal preferring: NOTCH3 peptide-reactive antibodies largely targeted ... the terminating free carboxyl group of the immunizing peptide. The antibodies that preferred C-terminal epitopes ...

    Abstract Antibodies raised in peptide-immunized rabbits have been used in biological research for decades. Although there has been wide implementation of this approach, specific proteins are occasionally difficult to target for multiple reasons. One consideration that was noted in mice is that humoral responses may preferentially target the carboxyl terminus of the peptide sequence which is not present in the intact protein. To shed light on the frequency of preferential rabbit antibody responses to C-termini of peptide immunogens, we present our experience with generation of rabbit antibodies to human NOTCH3. A total of 23 antibodies were raised against 10 peptide sequences of human NOTCH3. Over 70% (16 of 23) of these polyclonal antibodies were determined to be C-terminal preferring: NOTCH3 peptide-reactive antibodies largely targeted the terminating free carboxyl group of the immunizing peptide. The antibodies that preferred C-terminal epitopes reacted weakly or not at all with recombinant target sequences with extension the C-terminus that eliminated the free carboxyl group of the immunogen structure; furthermore, each of these antisera revealed no antibody reactivity to proteins truncated before the C-terminus of the immunogen. In immunocytochemical applications of these anti-peptide antibodies, we similarly found reactivity to recombinant targets that best binding to cells expressing the free C-terminus of the immunizing sequence. In aggregate, our experience demonstrates a strong propensity for rabbits to mount antibody responses to C-terminal epitopes of NOTCH3-derived peptides which is predicted to limit their use against the native protein. We discuss some potential approaches to overcome this bias that could improve the efficiency of generation of antibodies in this commonly utilized experimental paradigm.
    MeSH term(s) Rabbits ; Mice ; Humans ; Animals ; Antibody Formation ; Peptides/chemistry ; Amino Acid Sequence ; Antigens ; Antibodies ; Proteins ; Epitopes ; Peptide Fragments ; Receptor, Notch3
    Chemical Substances Peptides ; Antigens ; Antibodies ; Proteins ; Epitopes ; Peptide Fragments ; NOTCH3 protein, human ; Receptor, Notch3
    Language English
    Publishing date 2023-06-06
    Publishing country England
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, N.I.H., Extramural
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-023-36067-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Preferential rabbit antibody responses to C-termini of NOTCH3 peptide immunogens

    Soo Jung Lee / Mitchell B. Gasche / Connor J. Burrows / Akhil Kondepudi / Xiaojie Zhang / Michael M. Wang

    Scientific Reports, Vol 13, Iss 1, Pp 1-

    2023  Volume 9

    Abstract: ... To shed light on the frequency of preferential rabbit antibody responses to C-termini of peptide ... of these polyclonal antibodies were determined to be C-terminal preferring: NOTCH3 peptide-reactive antibodies largely targeted ... the terminating free carboxyl group of the immunizing peptide. The antibodies that preferred C-terminal epitopes ...

    Abstract Abstract Antibodies raised in peptide-immunized rabbits have been used in biological research for decades. Although there has been wide implementation of this approach, specific proteins are occasionally difficult to target for multiple reasons. One consideration that was noted in mice is that humoral responses may preferentially target the carboxyl terminus of the peptide sequence which is not present in the intact protein. To shed light on the frequency of preferential rabbit antibody responses to C-termini of peptide immunogens, we present our experience with generation of rabbit antibodies to human NOTCH3. A total of 23 antibodies were raised against 10 peptide sequences of human NOTCH3. Over 70% (16 of 23) of these polyclonal antibodies were determined to be C-terminal preferring: NOTCH3 peptide-reactive antibodies largely targeted the terminating free carboxyl group of the immunizing peptide. The antibodies that preferred C-terminal epitopes reacted weakly or not at all with recombinant target sequences with extension the C-terminus that eliminated the free carboxyl group of the immunogen structure; furthermore, each of these antisera revealed no antibody reactivity to proteins truncated before the C-terminus of the immunogen. In immunocytochemical applications of these anti-peptide antibodies, we similarly found reactivity to recombinant targets that best binding to cells expressing the free C-terminus of the immunizing sequence. In aggregate, our experience demonstrates a strong propensity for rabbits to mount antibody responses to C-terminal epitopes of NOTCH3-derived peptides which is predicted to limit their use against the native protein. We discuss some potential approaches to overcome this bias that could improve the efficiency of generation of antibodies in this commonly utilized experimental paradigm.
    Keywords Medicine ; R ; Science ; Q
    Subject code 570
    Language English
    Publishing date 2023-06-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Protein S100 as outcome predictor after out-of-hospital cardiac arrest and targeted temperature management at 33 °C and 36 °C.

    Stammet, Pascal / Dankiewicz, Josef / Nielsen, Niklas / Fays, François / Collignon, Olivier / Hassager, Christian / Wanscher, Michael / Undèn, Johan / Wetterslev, Jorn / Pellis, Tommaso / Aneman, Anders / Hovdenes, Jan / Wise, Matt P / Gilson, Georges / Erlinge, David / Horn, Janneke / Cronberg, Tobias / Kuiper, Michael / Kjaergaard, Jesper /
    Gasche, Yvan / Devaux, Yvan / Friberg, Hans

    Critical care (London, England)

    2017  Volume 21, Issue 1, Page(s) 153

    Abstract: ... °C and 36 °C) on serum levels of S100.: Methods: This is a substudy of the Target Temperature ... CI 0.77-0.83). S100 values were higher at 24 and 72 h in the 33 °C group than in the 36 °C group (0 ...

    Abstract Background: We aimed to investigate the diagnostic performance of S100 as an outcome predictor after out-of-hospital cardiac arrest (OHCA) and the potential influence of two target temperatures (33 °C and 36 °C) on serum levels of S100.
    Methods: This is a substudy of the Target Temperature Management after Out-of-Hospital Cardiac Arrest (TTM) trial. Serum levels of S100 were measured a posteriori in a core laboratory in samples collected at 24, 48, and 72 h after OHCA. Outcome at 6 months was assessed using the Cerebral Performance Categories Scale (CPC 1-2 = good outcome, CPC 3-5 = poor outcome).
    Results: We included 687 patients from 29 sites in Europe. Median S100 values were higher in patients with a poor outcome at 24, 48, and 72 h: 0.19 (IQR 0.10-0.49) versus 0.08 (IQR 0.06-0.11) μg/ml, 0.16 (IQR 0.10-0.44) versus 0.07 (IQR 0.06-0.11) μg/L, and 0.13 (IQR 0.08-0.26) versus 0.06 (IQR 0.05-0.09) μg/L (p < 0.001), respectively. The ability to predict outcome was best at 24 h with an AUC of 0.80 (95% CI 0.77-0.83). S100 values were higher at 24 and 72 h in the 33 °C group than in the 36 °C group (0.12 [0.07-0.22] versus 0.10 [0.07-0.21] μg/L and 0.09 [0.06-0.17] versus 0.08 [0.05-0.10], respectively) (p < 0.02). In multivariable analyses including baseline variables and the allocated target temperature, the addition of S100 improved the AUC from 0.80 to 0.84 (95% CI 0.81-0.87) (p < 0.001), but S100 was not an independent outcome predictor. Adding S100 to the same model including neuron-specific enolase (NSE) did not further improve the AUC.
    Conclusions: The allocated target temperature did not affect S100 to a clinically relevant degree. High S100 values are predictive of poor outcome but do not add value to present prognostication models with or without NSE. S100 measured at 24 h and afterward is of limited value in clinical outcome prediction after OHCA.
    Trial registration: ClinicalTrials.gov identifier: NCT01020916 . Registered on 25 November 2009.
    MeSH term(s) Aged ; Biomarkers/analysis ; Biomarkers/blood ; Body Temperature/physiology ; Brain Injuries/diagnosis ; Brain Injuries/etiology ; Europe/epidemiology ; Female ; Humans ; Hypothermia, Induced/adverse effects ; Hypothermia, Induced/methods ; Hypothermia, Induced/standards ; Male ; Middle Aged ; Out-of-Hospital Cardiac Arrest/diagnosis ; Out-of-Hospital Cardiac Arrest/epidemiology ; Out-of-Hospital Cardiac Arrest/mortality ; Patient Outcome Assessment ; Prognosis ; S100 Proteins/analysis ; S100 Proteins/blood
    Chemical Substances Biomarkers ; S100 Proteins
    Language English
    Publishing date 2017-06-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 2051256-9
    ISSN 1466-609X ; 1466-609X
    ISSN (online) 1466-609X
    ISSN 1466-609X
    DOI 10.1186/s13054-017-1729-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Predictive value of interleukin-6 in post-cardiac arrest patients treated with targeted temperature management at 33 °C or 36 °C.

    Bro-Jeppesen, John / Kjaergaard, Jesper / Stammet, Pascal / Wise, Matthew P / Hovdenes, Jan / Åneman, Anders / Horn, Janneke / Devaux, Yvan / Erlinge, David / Gasche, Yvan / Wanscher, Michael / Cronberg, Tobias / Friberg, Hans / Wetterslev, Jørn / Pellis, Tommaso / Kuiper, Michael / Nielsen, Niklas / Hassager, Christian

    Resuscitation

    2016  Volume 98, Page(s) 1–8

    Abstract: Aim: Post-cardiac arrest syndrome (PCAS) is characterized by systemic inflammation, however data on the prognostic value of inflammatory markers is sparse. We sought to investigate the importance of systemic inflammation, assessed by interleukin-6 (IL-6) ...

    Abstract Aim: Post-cardiac arrest syndrome (PCAS) is characterized by systemic inflammation, however data on the prognostic value of inflammatory markers is sparse. We sought to investigate the importance of systemic inflammation, assessed by interleukin-6 (IL-6) in comatose survivors of out-of-hospital cardiac arrest.
    Methods: A total of 682 patients enrolled in the Target Temperature Management (TTM) trial, surviving >24h with available IL-6 data were included. IL-6 was measured on days 1, 2 and 3 after return of spontaneous circulation. Severity of PCAS was assessed daily by the Sequential Organ Failure Assessment score. Survival status was recorded at 30 days.
    Results: High levels of IL-6 at day 1-3 (all p<0.0001) were independently associated with severity of PCAS with no interaction of target temperature (all p=NS). IL-6 levels did not differ between temperature groups (p(interaction)=0.99). IL-6 levels at day 2 (p<0.0001) and day 3 (p<0.0001) were associated with crude mortality. Adjusted Cox proportional-hazards analysis showed that a two-fold increase of IL-6 levels at day 2 (HR=1.15 (95% CI: 1.07-1.23), p=0.0002) and day 3 (HR=1.18 (95% CI: 1.09-1.27), p<0.0001) were associated with mortality. IL-6 levels at day 3 had the highest discriminative value in predicting mortality (AUC=0.66). IL-6 did not significantly improve 30-day mortality prediction compared to traditional prognostic factors (p=0.08).
    Conclusions: In patients surviving >24h following cardiac arrest, IL-6 levels were significantly elevated and associated with severity of PCAS with no significant influence of target temperature. High IL-6 levels were associated with increased mortality. Measuring levels of IL-6 did not provide incremental prognostic value.
    MeSH term(s) Aged ; Biomarkers/blood ; Coma ; Comorbidity ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Hypothermia, Induced/methods ; Interleukin-6/blood ; Male ; Middle Aged ; Organ Dysfunction Scores ; Out-of-Hospital Cardiac Arrest/blood ; Out-of-Hospital Cardiac Arrest/mortality ; Out-of-Hospital Cardiac Arrest/therapy ; Predictive Value of Tests ; Prognosis ; Survival Rate
    Chemical Substances Biomarkers ; Interleukin-6
    Language English
    Publishing date 2016-01
    Publishing country Ireland
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 189901-6
    ISSN 1873-1570 ; 0300-9572
    ISSN (online) 1873-1570
    ISSN 0300-9572
    DOI 10.1016/j.resuscitation.2015.10.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia.

    Iqbal, Tariq / Stein, Jürgen / Sharma, Naveen / Kulnigg-Dabsch, Stefanie / Vel, Senthil / Gasche, Christoph

    Digestive diseases and sciences

    2015  Volume 60, Issue 5, Page(s) 1375–1381

    Abstract: ... inflammation at initiation of treatment (assessed by C-reactive protein [CRP] and interleukin-6 [IL-6 ...

    Abstract Background: Iron deficiency anemia (IDA) is a common complication of inflammatory bowel disease (IBD). In clinical practice, many patients receive initial treatment with iron tablets although intravenous (i.v.) iron supplementation is often preferable.
    Aim: This study investigated whether systemic inflammation at initiation of treatment (assessed by C-reactive protein [CRP] and interleukin-6 [IL-6] measurements) predicts response to iron therapy.
    Methods: Data from a previously published phase III trial were retrospectively analyzed after stratification of patients according to baseline CRP (> 4 vs. ≤ 4 mg/L) and IL-6 (> 6 vs. ≤ 6 pg/mL) levels. The study population consisted of patients with Crohn's disease or ulcerative colitis and IDA (Hb ≤ 110 g/L and TSAT < 20 % or serum ferritin < 100 ng/mL), randomized to either oral (ferrous sulfate) or i.v. iron (ferric carboxymaltose).
    Results: A total of 196 patients were evaluated (oral iron: n = 60; i.v. iron: n = 136). Baseline CRP and IL-6 levels were independent of patients' initial Hb levels and iron status (serum ferritin and TSAT; all p > 0.05). Among iron tablet-treated patients, Hb increase was significantly smaller in the high- versus low-CRP subgroup (1.1 vs. 2.0, 2.3 vs. 3.1, and 3.0 vs. 4.0 g/dL at weeks 2, 4, and 8, respectively; all p < 0.05). Differences were less pronounced with stratification according to baseline IL-6. Response to i.v. iron was mainly independent of inflammation.
    Conclusions: Patients with high baseline CRP achieved a lower Hb response with oral iron therapy. Our results suggest that CRP may be useful to identify IBD patients who can benefit from first-line treatment with i.v. iron to improve their IDA.
    MeSH term(s) Administration, Intravenous ; Administration, Oral ; Anemia, Iron-Deficiency/blood ; Anemia, Iron-Deficiency/diagnosis ; Anemia, Iron-Deficiency/drug therapy ; Anemia, Iron-Deficiency/immunology ; Biomarkers/blood ; C-Reactive Protein/analysis ; Clinical Trials, Phase III as Topic ; Colitis, Ulcerative/blood ; Colitis, Ulcerative/diagnosis ; Colitis, Ulcerative/immunology ; Crohn Disease/blood ; Crohn Disease/diagnosis ; Crohn Disease/immunology ; Ferric Compounds/administration & dosage ; Ferrous Compounds/administration & dosage ; Hematinics/administration & dosage ; Hemoglobins/metabolism ; Humans ; Inflammation Mediators/blood ; Interleukin-6/blood ; Maltose/administration & dosage ; Maltose/analogs & derivatives ; Randomized Controlled Trials as Topic ; Retrospective Studies ; Time Factors ; Treatment Outcome
    Chemical Substances Biomarkers ; Ferric Compounds ; Ferrous Compounds ; Hematinics ; Hemoglobins ; IL6 protein, human ; Inflammation Mediators ; Interleukin-6 ; ferrous sulfate (39R4TAN1VT) ; ferric carboxymaltose (6897GXD6OE) ; Maltose (69-79-4) ; C-Reactive Protein (9007-41-4)
    Language English
    Publishing date 2015-05
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 304250-9
    ISSN 1573-2568 ; 0163-2116
    ISSN (online) 1573-2568
    ISSN 0163-2116
    DOI 10.1007/s10620-014-3460-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Ursachen, Diagnostik und Therapieoptionen: Eisenmangel bei der Frau

    Gasche, A. / Gasche, C.

    Gyn-aktiv

    2021  Volume -, Issue 5, Page(s) 37

    Language German
    Document type Article
    ZDB-ID 2213296-X
    ISSN 1605-8828
    Database Current Contents Medicine

    More links

    Kategorien

  7. Article ; Online: Endoscopic retrograde appendicitis therapy: new approach in the treatment of stump appendicitis.

    Haller, Felix / Gasche, Christoph

    Endoscopy

    2021  Volume 54, Issue 1, Page(s) E15–E16

    MeSH term(s) Appendectomy ; Appendicitis/diagnostic imaging ; Appendicitis/surgery ; Endoscopy ; Humans ; Postoperative Complications
    Language English
    Publishing date 2021-02-16
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 80120-3
    ISSN 1438-8812 ; 0013-726X
    ISSN (online) 1438-8812
    ISSN 0013-726X
    DOI 10.1055/a-1346-8677
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: WMW Themenheft Eisenstoffwechsel.

    Gasche, Christoph

    Wiener medizinische Wochenschrift (1946)

    2016  Volume 166, Issue 13-14, Page(s) 401

    Title translation WMW special issue on iron metabolism.
    MeSH term(s) Iron/metabolism ; Iron Metabolism Disorders
    Chemical Substances Iron (E1UOL152H7)
    Language German
    Publishing date 2016-10
    Publishing country Austria
    Document type Editorial ; Introductory Journal Article
    ZDB-ID 123613-1
    ISSN 1563-258X ; 0254-7945 ; 0043-5341
    ISSN (online) 1563-258X
    ISSN 0254-7945 ; 0043-5341
    DOI 10.1007/s10354-016-0507-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Pericardial Tamponade following Asymptomatic SARS-CoV-2 Infection: A Diagnostic Journey.

    Birner, Christian / Gasche, Matthias / Voisard, Rainer / Neumann, Christian

    Case reports in cardiology

    2022  Volume 2022, Page(s) 1332844

    Abstract: ... ...

    Abstract Background
    Language English
    Publishing date 2022-09-22
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2627627-6
    ISSN 2090-6412 ; 2090-6404
    ISSN (online) 2090-6412
    ISSN 2090-6404
    DOI 10.1155/2022/1332844
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Eisensubstitution - one size does not fit all

    Frick, A. / Gasche, C.

    Universum Innere Medizin

    2021  Volume -, Issue 7, Page(s) 91

    Language German
    Document type Article
    ZDB-ID 2475266-6
    ISSN 1607-8861
    Database Current Contents Medicine

    More links

    Kategorien

To top